Portfolio company
Neuronetix
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Neuronetix develops a point-of-care blood test to quantify and objectively diagnose concussions in student athletes and other patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cortirio
Cortirio develops portable brain imaging headsets that use infrared light to diagnose strokes and traumatic brain injuries at the point of care.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
GLX Analytix
This company develops blood-based diagnostic and monitoring tests for clinicians to manage neurodegenerative, autoimmune and neuropsychiatric diseases using glycocalyx biomarkers and artificial intelligence.
CranioSense
This company develops non-invasive diagnostic systems to monitor intracranial pressure for emergency care teams and clinicians treating traumatic brain injuries.
Beyond Barriers Therapeutics
This biotechnology company develops field-ready intranasal therapeutics for patients suffering from concussions and traumatic brain injuries.
NeuraLight
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
neuroClues
This company develops portable eye-tracking medical devices and AI software for clinicians to identify neurological disorders through ocular biomarkers.
Neuronostics
The company develops an EEG-based digital biomarker platform to provide objective diagnostic and prognostic support for epilepsy to healthcare providers and pharmaceutical researchers.